2015
DOI: 10.1111/aji.12412
|View full text |Cite
|
Sign up to set email alerts
|

Soluble Immune Mediators and Vaginal Bacteria Impact Innate Genital Mucosal Antimicrobial Activity in Young Women

Abstract: Introduction Innate activity against Escherichia coli in female genital secretions may represent contributions from vaginal bacteria and host soluble immune mediators. We analyzed the relationship between E. coli inhibitory activity, soluble immune mediators, and vaginal bacteria in participants in MTN-004, a placebo-controlled trial of VivaGel®, a candidate product for topical HIV pre-exposure prophylaxis. Methods Escherichia coli inhibitory activity was quantified by colony reduction assay. Endocervical co… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
7
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 14 publications
(7 citation statements)
references
References 43 publications
0
7
0
Order By: Relevance
“…In particular, a dendrimer-based drug Vivagel ® preventing the HIV infection has been approved for using in condom lubricants [ 96 , 97 ]. It has also been subjected to clinical trials in the bacterial vaginosis treatment [ 98 , 99 ]. These recent positive findings stimulate the development of new dendrimer-based constructions for future medicine.…”
Section: Complexes and Conjugates Of Proteins And Peptides With Dementioning
confidence: 99%
“…In particular, a dendrimer-based drug Vivagel ® preventing the HIV infection has been approved for using in condom lubricants [ 96 , 97 ]. It has also been subjected to clinical trials in the bacterial vaginosis treatment [ 98 , 99 ]. These recent positive findings stimulate the development of new dendrimer-based constructions for future medicine.…”
Section: Complexes and Conjugates Of Proteins And Peptides With Dementioning
confidence: 99%
“… 6–9 Inflammatory processes can recruit HIV-infected or target cells to the genitalia, thereby increasing risks of both transmission and acquisition. Studies of inflammatory markers confirm that cells are associated with high viral loads (VL) in cervico-vaginal fluids, 10 and cytokine markers 11–14 and innate antimicrobial responses 15 , 16 are linked to HIV acquisition. Causes of these inflammatory processes warrant closer investigation.…”
Section: Introductionmentioning
confidence: 99%
“…Recently, one dendrimer-containing gel drug, Vivagel ® , has been approved by the US FDA for the use in condom lubricants to prevent the HIV infection [ 8 , 9 ]. It is subjected for clinical trials as a therapeutic to treat bacterial vaginosis as well [ 10 , 11 ]. This recent success encourages the development of new dendrimer-containing constructions and materials for innovative medicine.…”
Section: Introductionmentioning
confidence: 99%